MicroRNA-28 potentially regulates the photoreceptor lineage commitment of Müller glia-derived progenitors

Hong-Pei Ji1,2, Yu Xiong1, Wei-Tao Song1

  • 1Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, 410008, China.

Scientific Reports
|September 14, 2017
PubMed

Insights

Müller glia can become retinal progenitor cells for cell replacement therapy. MicroRNA-28 inhibition promotes these cells to develop into photoreceptors by targeting the CRX transcription factor.

Area of Science:

  • Ophthalmology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Retinal degenerative diseases cause irreversible photoreceptor loss.
  • Cell replacement therapy using stem/progenitor cells is a promising treatment.
  • Müller glia exhibit progenitor cell characteristics, making them potential seed cells for retinal repair.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in the differentiation of Müller glia-derived progenitors (MGDPs) into photoreceptors.
  • To identify specific miRNAs that regulate photoreceptor lineage commitment in MGDPs.

Main Methods:

  • Isolation and in vitro culture of mouse retinal Müller glia to generate MGDPs.
  • Bioinformatic analysis (TargetScan, Miranda, Pictar) to predict miRNA targets.
  • Gain- and loss-of-function experiments (anti-miR-28, miR-28 mimic, siRNA for CRX) and dual luciferase assays to validate miRNA-target interactions.

Main Results:

  • MGDPs expressed stem/progenitor markers (Nestin, Sox2) and showed self-renewal capacity.
  • miR-28 was identified as a direct target of the photoreceptor transcription factor CRX.
  • Inhibition of miR-28 promoted MGDP differentiation into CRX- and Rhodopsin-expressing neurons, while miR-28 mimic suppressed this.
  • CRX knockdown blocked the pro-differentiation effects of anti-miR-28.

Conclusions:

  • miR-28 plays a crucial role in regulating photoreceptor differentiation of MGDPs by targeting CRX.
  • Targeting miR-28 offers a potential strategy for inducing photoreceptor commitment in cell replacement therapy for retinal degenerative diseases.
  • Further research is needed to confirm the role of this pathway in vivo.

Related Concept Videos